UBS Group’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $176M | Sell |
1,200,416
-317,986
| -21% | -$49M | 0.03% | 680 |
|
|
2025
Q4 | $235M | Buy |
1,518,402
+365,502
| +32% | +$54.7M | 0.04% | 498 |
|
|
2025
Q3 | $160M | Sell |
1,152,900
-79,100
| -6% | -$10.7M | 0.03% | 706 |
|
|
2025
Q2 | $166M | Buy |
1,232,000
+405,800
| +49% | +$54.8M | 0.03% | 629 |
|
|
2025
Q1 | $121M | Sell |
826,200
-83,200
| -9% | -$12.1M | 0.02% | 809 |
|
|
2024
Q4 | $125M | Buy |
909,400
+380,300
| +72% | +$55.7M | 0.02% | 778 |
|
|
2024
Q3 | $81.5M | Buy |
529,100
+398,600
| +305% | +$60.4M | 0.02% | 846 |
|
|
2024
Q2 | $19M | Sell |
130,500
-555,900
| -81% | -$79.7M | ﹤0.01% | 1725 |
|
|
2024
Q1 | $101M | Buy |
686,400
+567,300
| +476% | +$81.4M | 0.03% | 640 |
|
|
2023
Q4 | $16.2M | Sell |
119,100
-184,900
| -61% | -$24.1M | ﹤0.01% | 1732 |
|
|
2023
Q3 | $39.1M | Sell |
304,000
-114,700
| -27% | -$15.2M | 0.01% | 1005 |
|
|
2023
Q2 | $55.6M | Sell |
418,700
-155,300
| -27% | -$20.5M | 0.02% | 773 |
|
|
2023
Q1 | $74.3M | Buy |
574,000
+360,800
| +169% | +$47.1M | 0.03% | 577 |
|
|
2022
Q4 | $29M | Sell |
213,200
-357,100
| -63% | -$47.3M | 0.01% | 1160 |
|
|
2022
Q3 | $69.1M | Buy |
570,300
+105,000
| +23% | +$13.5M | 0.03% | 557 |
|
|
2022
Q2 | $59.7M | Buy |
465,300
+217,800
| +88% | +$28.5M | 0.02% | 638 |
|
|
2022
Q1 | $33.9M | Sell |
247,500
-681,800
| -73% | -$90.3M | 0.01% | 1082 |
|
|
2021
Q4 | $131M | Sell |
929,300
-1,111,400
| -54% | -$148M | 0.04% | 491 |
|
|
2021
Q3 | $260M | Buy |
2,040,700
+186,900
| +10% | +$24.7M | 0.08% | 241 |
|
|
2021
Q2 | $233M | Buy |
1,853,800
+503,800
| +37% | +$61.7M | 0.08% | 260 |
|
|
2021
Q1 | $158M | Sell |
1,350,000
-1,200
| -0.1% | -$139K | 0.05% | 342 |
|
|
2020
Q4 | $153M | Buy |
1,351,200
+230,800
| +21% | +$25.2M | 0.05% | 349 |
|
|
2020
Q3 | $118M | Buy |
1,120,400
+1,011,700
| +931% | +$106M | 0.04% | 356 |
|
|
2020
Q2 | $10.9M | Sell |
108,700
-16,300
| -13% | -$1.61M | ﹤0.01% | 1439 |
|
|
2020
Q1 | $11.1M | Sell |
125,000
-50,000
| -29% | -$4.86M | 0.01% | 1331 |
|
|
2019
Q4 | $17.8M | Sell |
175,000
-263,100
| -60% | -$25.3M | 0.01% | 1461 |
|
|
2019
Q3 | $39.5M | Buy |
438,100
+339,500
| +344% | +$31M | 0.02% | 813 |
|
|
2019
Q2 | $9.13M | Buy |
98,600
+70,000
| +245% | +$6.29M | ﹤0.01% | 1833 |
|
|
2019
Q1 | $2.62M | Buy |
28,600
+20,700
| +262% | +$1.87M | ﹤0.01% | 2751 |
|
|
2018
Q4 | $683K | Buy |
7,900
+4,300
| +119% | +$389K | ﹤0.01% | 4018 |
|
|
2018
Q3 | $343K | Hold |
3,600
| – | – | ﹤0.01% | 4664 |
|
|
2018
Q2 | $300K | Sell |
3,600
-745,000
| -100% | -$61.7M | ﹤0.01% | 4688 |
|
|
2018
Q1 | $60.9M | Sell |
748,600
-233,100
| -24% | -$19.9M | 0.03% | 546 |
|
|
2017
Q4 | $81.2M | Buy |
981,700
+557,100
| +131% | +$45.9M | 0.03% | 478 |
|
|
2017
Q3 | $34.7M | Buy |
424,600
+418,600
| +6,977% | +$33.6M | 0.02% | 797 |
|
|
2017
Q2 | $475K | Sell |
6,000
-315,000
| -98% | -$24M | ﹤0.01% | 4146 |
|
|
2017
Q1 | $23.9M | Sell |
321,000
-1,085,100
| -77% | -$79.1M | 0.01% | 924 |
|
|
2016
Q4 | $96.9M | Buy |
1,406,100
+259,200
| +23% | +$18M | 0.05% | 340 |
|
|
2016
Q3 | $82.7M | Buy |
1,146,900
+230,900
| +25% | +$17M | 0.05% | 369 |
|
|
2016
Q2 | $65.7M | Buy |
916,000
+122,500
| +15% | +$8.63M | 0.04% | 406 |
|
|
2016
Q1 | $53.8M | Sell |
793,500
-2,700
| -0.3% | -$181K | 0.04% | 444 |
|
|
2015
Q4 | $57.4M | Hold |
796,200
| – | – | 0.04% | 467 |
|
|
2015
Q3 | $52.7M | Sell |
796,200
-403,600
| -34% | -$29.5M | 0.04% | 451 |
|
|
2015
Q2 | $89.3M | Buy |
1,199,800
+301,400
| +34% | +$22.3M | 0.06% | 332 |
|
|
2015
Q1 | $65.1M | Buy |
898,400
+886,000
| +7,145% | +$63.2M | 0.05% | 426 |
|
|
2014
Q4 | $848K | Buy |
+12,400
| New | +$830K | ﹤0.01% | 3708 |
|
Other funds holding XLV
HIIFS
UBS Group's XLV Position: Q1 2026 in Review
UBS Group reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 4.1% in Q1 2026, selling an estimated $29.9M and leaving 4,528,081 shares worth $664M. The position accounts for 0.1% of the portfolio, ranked #200.
UBS Group first reported a position in XLV in Q4 2014 and has held it in 46 quarters since. The position peaked at $731M in Q4 2025. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.
- UBS Group held 4,528,081 shares of State Street Health Care Select Sector SPDR ETF worth $664M as of Q1 2026.
- UBS Group sold 193,663 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $29.9M.
- State Street Health Care Select Sector SPDR ETF made up 0.1% of UBS Group's portfolio in Q1 2026, its #200 holding.
- UBS Group first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2014 and has held it in 46 quarters since.
- UBS Group's State Street Health Care Select Sector SPDR ETF position peaked at $731M in Q4 2025.
- 1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.